Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Paraphrase, not own words

Rules 1.1.0 · as of 14 Sep 2026

Quote

Paraphrase, not own words

“In 2018, Angermayer predicted FDA approval of COMP360 for TRD by 2021.”
· The shifting fortunes of corporate psychedelia (Finance and Society, Cambridge), citing E. Brodwin, Business Insider, 3 Oct 2018 · article

Compass Pathways' psilocybin (COMP360) would win FDA approval for treatment-resistant depression by 2021.

The only record of the claim is a third party's paraphrase or a secondhand report; the forecaster's own words are not available. Shown as a row, never coded or scored.